Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma

BACKGROUND: The immunological inflammatory biomarkers for advanced hepatocellular carcinoma are unclear. We aimed to investigate the association of immunity and inflammatory status with treatment outcomes in patients with advanced hepatocellular carcinoma who received molecular-targeted agents as pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakano, M., Kuromatsu, R., Niizeki, T., Okamura, S., Iwamoto, H., Shimose, S., Shirono, T., Noda, Y., Kamachi, N., Koga, H., Torimura, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807940/
https://www.ncbi.nlm.nih.gov/pubmed/33399083
http://dx.doi.org/10.1016/j.esmoop.2020.100020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807940/
https://www.ncbi.nlm.nih.gov/pubmed/33399083
http://dx.doi.org/10.1016/j.esmoop.2020.100020

Ejemplares similares